Categories: News

Clear Vision Center Now Providing Cutting-Edge LASIK Alternative for Patients Over 45

ROCHESTER, MI / ACCESSWIRE / July 10, 2024 / Clear Vision Center, a premium cataract and LASIK practice serving Metro Detroit, announces the availability of Custom Lens Replacement (CLR) for patients over 45. This procedure offers a long-lasting solution for vision issues related to aging eyes, including presbyopia and early-stage cataracts.

Presbyopia is an age-related condition characterized by the gradual loss of the eye’s ability to focus on close objects. It often results in difficulty reading small print and performing close-up tasks.

CLR, also known as refractive lens exchange (RLE), is similar to cataract surgery. It replaces the eye’s natural lens with an artificial lens, designed to improve vision and potentially eliminate the need for glasses or contact lenses.

Dr. Joshua Vrabec, Board-Certified Ophthalmologist and founder of Clear Vision Center, states, “CLR is a game-changer for candidates over 45 who want to reduce their dependence on glasses. It not only corrects current vision issues but also prevents future cataract development, offering a comprehensive solution for long-term vision needs.”

The procedure takes 10-15 minutes per eye and is painless. CLR can correct nearsightedness, farsightedness, astigmatism, and presbyopia, potentially freeing patients from reliance on corrective lenses for common activities.

One advantage of CLR is that it eliminates the need for future cataract surgery. By replacing the natural lens before cataracts fully develop, patients can avoid the gradual vision decline associated with cataracts.

Clear Vision Center offers various advanced technology lens options to suit individual patient needs. These include multifocal and adjustable lens technologies for those seeking distance, midrange, and near vision correction. For patients prioritizing distance and midrange vision, advanced single-focus options that correct astigmatism are available. Dr. Vrabec and his team carefully evaluate each patient’s vision goals to recommend the most suitable lens combination, ensuring optimal outcomes and patient satisfaction.

While CLR is typically recommended for those over 45, younger patients who are not LASIK candidates may be considered on a case-by-case basis. The procedure is not covered by insurance when performed before significant cataract development, but financing options are available.

As an independently owned and operated practice, Clear Vision Center prides itself on providing personalized care without influence from large hospital systems or outside ownership groups. With over 25 years of experience in ophthalmology and state-of-the-art diagnostic technology, the center ensures each patient receives the highest quality care tailored to their unique needs. Dr. Vrabec emphasizes that all potential candidates for CLR are meticulously screened for their overall eye health prior to the procedure, and the specific lens recommendations are highly customized to the individual to ensure the best outcomes. Due to individual variances, not everyone is a good candidate for vision correction procedures such as CLR or LASIK.

Patients interested in learning more about Custom Lens Replacement are encouraged to schedule a consultation with Clear Vision Center.

For more information or to schedule a consultation, please contact Clear Vision Center.

Contact Information

Joshua Vrabec
Board-Certified Ophthalmologist
joshvrabec@clearvisioncenter.com

SOURCE: Clear Vision Center

View the original press release on newswire.com.

View the original press release on accesswire.com

Staff

Recent Posts

Daily Fit Notes Rolls Out Affordable Fitness Solutions for the Modern Lifestyle

Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…

2 days ago

WillowWood Rebrand by DD.NYC Wins Gold Anthem Award for Product and Innovation in 2024 Rebrand

MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…

2 days ago

Quantum Biopharma Announces Closing of Second Tranche

TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…

2 days ago

Glow Lifetech Announces Completion of Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…

2 days ago